TY  - JOUR
AU  - Martín, Ernesto
AU  - López-Aguilera, José
AU  - González-Manzanares, Rafael
AU  - Anguita, Manuel
AU  - Gutiérrez, Guillermo
AU  - Luque, Aurora
AU  - Paredes, Nick
AU  - Oneto, Jesús
AU  - Perea, Jorge
AU  - Castillo, Juan Carlos
PY  - 2021
DO  - 10.3390/jcm10030505
UR  - http://hdl.handle.net/10668/4137
T2  - Journal of Clinical Medicine
AB  - Background: Heart failure (HF) is one of the mayor contributors to cardiovascular morbidity and mortality in patients with diabetes. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have demonstrated to reduce the risk of hospitalization for HF in...
LA  - en
PB  - MDPI
KW  - Heart failure
KW  - Readmissions
KW  - Canagliflozin
KW  - Sodium glucose co-transporter 2 inhibitor
KW  - N-terminal pro-B-type natriuretic peptide
KW  - Type 2 diabetes mellitus
KW  - Insuficiencia cardíaca
KW  - Readmisión del paciente
KW  - Canagliflozina
KW  - Inhibidores del cotransportador de sodio-glucosa 2
KW  - Péptidos natriuréticos
KW  - Diabetes mellitus tipo 2
KW  - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
KW  - Medical Subject Headings::Chemicals and Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Peptide Hormones::Natriuretic Peptides::Natriuretic Peptide, Brain
KW  - Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Membrane Transport Proteins::Ion Pumps::Symporters::Sodium-Glucose Transport Proteins::Sodium-Glucose Transporter 2
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Patient Care::Hospitalization::Patient Readmission
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Patient Care::Hospitalization::Patient Discharge
KW  - Medical Subject Headings::Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Diabetes Mellitus::Diabetes Mellitus, Type 2
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal...
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Confidence Intervals
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Research Design::Control Groups
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies::Retrospective Studies
KW  - Medical Subject Headings::Diseases::Cardiovascular Diseases::Heart Diseases::Heart Failure
KW  - Medical Subject Headings::Health Care::Health Care Facilities, Manpower, and Services::Health Services::Pharmaceutical Services::Prescriptions
TI  - Impact of Canagliflozin in Patients with Type 2 Diabetes after Hospitalization for Acute Heart Failure: A Cohort Study
TY  - research article
ER  -